Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-07-12 @ 3:42 AM
Study NCT ID:
NCT05447702
Status:
RECRUITING
Last Update Posted:
2023-05-22
First Post:
2022-06-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
Sponsor:
West China Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Triple Negative Breast Cancer | View |
Keywords: